Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus.
Our current knowledge on foot-and-mouth disease virus (FMDV) entry into error catastrophe is reviewed. FMDV can establish cytolytic and persistent infections in the field and in cell culture. Both types of FMDV infection in cell culture can be treated with mutagens, with or without classical (non-mutagenic) antiviral inhibitors, to drive the virus to extinction. 5-Fluorouracil (FU) and 5-azacytidine (AZC) have been employed as mutagenic agents to treat cytolytic FMDV infections, and ribavirin (Rib) to treat persistent infections. Extinction is dependent on the relative fitness of the viral isolate, as well as on the viral load. In cytolytic infections, extinctions could be efficiently obtained with combinations of mutagens and inhibitors. High-fitness FMDV extinction could only be achieved with treatments that contained a mutagen, and not with combinations of inhibitors that exerted the same antiviral effect. Persistent infections could be cured with Rib treatment alone. The results presented here show entry into error catastrophe as a valid strategy for treatment of viral infections, although much work remains to be done before it can be implemented.
Pariente
Nonia
N
Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Sierra
Saleta
S
Airaksinen
Antero
A
D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D001374:Azacitidine / Q000737:chemistry / Q000494:pharmacology; D002460:Cell Line; D006224:Cricetinae; D005472:Fluorouracil / Q000737:chemistry / Q000494:pharmacology; D029544:Foot-and-Mouth Disease Virus / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D009153:Mutagens / Q000737:chemistry / Q000494:pharmacology*; D012254:Ribavirin / Q000737:chemistry / Q000494:pharmacology
D000998:Antiviral Agents; D009153:Mutagens; D012254:Ribavirin; D001374:Azacitidine; D005472:Fluorouracil